IP Verse

Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release Tablets

PatentPatent Analysis

EP3102187

GALENICUM HEALTH SL
Application Number
EP15702266A
Filing Date
Feb 3, 2015
Status
Revoked
Dec 20, 2024
Grant Date
Mar 25, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3512505B1
EP3240529B1
EP2915526B1

Biblio Summary

The patent EP3102187B1 was granted to Galenicum Health SL on Mar 25, 2020 following the initial filing on Feb 3, 2015 under the application number EP15702266A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COOKEDec 30, 2020ADMISSIBLE
DENTONS PATENT SOLUTIONSDec 23, 2020ADMISSIBLE
DENTONS UK AND MIDDLE EASTDec 23, 2020ADMISSIBLE
LABORATORIOS LICONSADec 23, 2020ADMISSIBLE
MULLENDec 19, 2020ADMISSIBLE
HOFFMANN EITLEDec 18, 2020ADMISSIBLE
ELKINGTON AND FIFEDec 17, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents